These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 9196111
21. A pilot study of low-dose erythromycin in bronchiectasis. Tsang KW, Ho PI, Chan KN, Ip MS, Lam WK, Ho CS, Yuen KY, Ooi GC, Amitani R, Tanaka E. Eur Respir J; 1999 Feb; 13(2):361-4. PubMed ID: 10065682 [Abstract] [Full Text] [Related]
25. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Drobnic ME, Suñé P, Montoro JB, Ferrer A, Orriols R. Ann Pharmacother; 2005 Jan 01; 39(1):39-44. PubMed ID: 15562142 [Abstract] [Full Text] [Related]
26. Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis. Daviskas E, Anderson SD, Eberl S, Young IH. Eur Respir J; 2008 Apr 01; 31(4):765-72. PubMed ID: 18057051 [Abstract] [Full Text] [Related]
27. Effect of H1- and H2-receptor antagonists on sputum volume and lung function in patients with generalized bronchiectasis. Anderson J, Eiser NM, Mills JG. Br J Dis Chest; 1985 Jul 01; 79(3):272-4. PubMed ID: 2861844 [Abstract] [Full Text] [Related]
28. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Richman-Eisenstat JB, Jorens PG, Hébert CA, Ueki I, Nadel JA. Am J Physiol; 1993 Apr 01; 264(4 Pt 1):L413-8. PubMed ID: 8476069 [Abstract] [Full Text] [Related]
29. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis. Nicolson CH, Stirling RG, Borg BM, Button BM, Wilson JW, Holland AE. Respir Med; 2012 May 01; 106(5):661-7. PubMed ID: 22349069 [Abstract] [Full Text] [Related]
30. Nebulised gentamicin-suitable for childhood bronchiectasis. Twiss J, Byrnes C, Johnson R, Holland D. Int J Pharm; 2005 May 13; 295(1-2):113-9. PubMed ID: 15847996 [Abstract] [Full Text] [Related]
33. Quality of life and inflammation in exacerbations of bronchiectasis. Courtney JM, Kelly MG, Watt A, Garske L, Bradley J, Ennis M, Elborn JS. Chron Respir Dis; 2008 May 13; 5(3):161-8. PubMed ID: 18684792 [Abstract] [Full Text] [Related]
35. [Pilot study of amiloride inhalation in children with cystic fibrosis]. Riedler J, Huttegger I. Klin Padiatr; 1992 May 13; 204(3):158-62. PubMed ID: 1614182 [Abstract] [Full Text] [Related]
36. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Llewellyn-Jones CG, Harris TA, Stockley RA. Am J Respir Crit Care Med; 1996 Feb 13; 153(2):616-21. PubMed ID: 8564107 [Abstract] [Full Text] [Related]
37. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease. Gehrig S, Duerr J, Weitnauer M, Wagner CJ, Graeber SY, Schatterny J, Hirtz S, Belaaouaj A, Dalpke AH, Schultz C, Mall MA. Am J Respir Crit Care Med; 2014 May 01; 189(9):1082-92. PubMed ID: 24678594 [Abstract] [Full Text] [Related]
40. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum. Tomkiewicz RP, App EM, Zayas JG, Ramirez O, Church N, Boucher RC, Knowles MR, King M. Am Rev Respir Dis; 1993 Oct 01; 148(4 Pt 1):1002-7. PubMed ID: 8214916 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]